The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 24, 2015

Filed:

Jun. 13, 2011
Applicants:

Mengzhuang Cai, Pudong, CN;

Qian Liu, Pudong, CN;

GE Xu, Pudong New District, CN;

Binhua LV, Pudong New District, CN;

Brian Seed, Boston, MA (US);

Jacques Y. Roberge, Princeton, NJ (US);

Inventors:

Mengzhuang Cai, Pudong, CN;

Qian Liu, Pudong, CN;

Ge Xu, Pudong New District, CN;

Binhua Lv, Pudong New District, CN;

Brian Seed, Boston, MA (US);

Jacques Y. Roberge, Princeton, NJ (US);

Assignee:

Theracos, Inc., Marlborough, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/16 (2006.01); A61K 31/35 (2006.01); A01N 43/02 (2006.01); A61K 31/335 (2006.01); A01N 43/00 (2006.01); A61K 31/33 (2006.01); C07D 315/00 (2006.01); C07D 309/10 (2006.01);
U.S. Cl.
CPC ...
C07D 309/10 (2013.01);
Abstract

Provided are crystalline forms of a compound having an inhibitory effect on sodium-dependent glucose cotransporter SGLT2. The invention also provides pharmaceutical compositions, methods of preparing the crystalline compound, and methods of using the crystalline compound, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by SGLT or SGLT2 inhibition.


Find Patent Forward Citations

Loading…